Press Release
May 9, 2023
Geneva, Switzerland, May 9th, 2023
Firmenich International SA ("Firmenich") is announcing the completion of its merger with DSM to establish DSM-Firmenich AG, the leading innovation partner in nutrition, health, and beauty. This announcement is being made following receipt of all customary conditions, completion of the merger transaction’s share exchange offer and the contribution of Firmenich shares into DSM-Firmenich AG.
As a result of the completion of the merger transaction, the Firmenich directors have resigned from the Board of Firmenich. Jane Sinclair, Geraldine Matchett and Dimitiri de Vreeze have been appointed to the Board of Firmenich.
Disclosure
The information was submitted for publication, through the contact persons set out below, at 02:55 CEST on 9 May 2023. Further information, is available on DSM-Firmenich | DSM-Firmenich.com.
Contact
Firmenich
Ingvild Van Lysebetten
Investor Relations
Email: investor_relations@firmenich.com
Telephone: +41 79 833 7252
Firmenich media enquiries:
Brunswick Group
Joseph Chi Lo, Ed Brown
Email: firmenichir@brunswickgroup.com
Telephone: +44 20 7404 5959
About Firmenich
Firmenich, the world’s largest privately-owned fragrance and taste company, was founded in Geneva, Switzerland, in 1895, and has been family-owned for 125 years. Firmenich is a leading business-to-business company specialized in the research, creation, manufacture and sale of perfumes, flavors and ingredients. Renowned for its world-class research and creativity, as well as its leadership in sustainability, Firmenich offers its customers superior innovation in formulation, a broad and high-quality palette of ingredients, and proprietary technologies including biotechnology, encapsulation, olfactory science and taste modulation. Firmenich had an annual turnover of 3.9 billion Swiss Francs at end June 2020. More information about Firmenich is available at www.firmenich.com.